- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02639624
Altering Bicarbonate Delivery During Hemodialysis to Affect Filtration of Indoxyl Sulfate
July 27, 2017 updated by: NYU Langone Health
This is a non randomized crossover trial investigating whether changing the pattern of bicarbonate administration during hemodialysis will result in the more efficient filtration of highly protein bound solutes.
The experimental group will be dialyzed with low bicarbonate dialysate for the first half of dialysis then switched over to normal bicarbonate dialysate for the second half.
The control group will be dialyzed entirely with normal bicarbonate dialysate.
The two groups will switch one week late and patients will serve as their own matched controls for a completely standard dialysis and one that is split into two halves with different bicarbonate concentrations.
Study Overview
Status
Withdrawn
Conditions
Detailed Description
Investigators will try to perform dialysis with a low bicarbonate bath which will leave patients blood pH (Hydrogen ion concentration) relatively unchanged then switch to a normal bicarbonate bath during the second half of dialysis so that they attain the pH (Hydrogen ion concentration) they normally would.
Investigators will use these measurements to test test the hypothesis that Indoxyl Sulfate (IS) binds to proteins with greater affinity under basic conditions and further to test the hypothesis that it is possible to remove a greater amount of Indoxyl Sulfate (IS) when patients are maintained relatively acidotic during dialysis for a longer period of time due to the greater availability of free IS that can pass through the dialyzer.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- New York University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Chronic Stable Dialysis for at least 6 months
Exclusion Criteria:
- Patients with serum potassium concentration below 4.0 mEq/L on previous monthly lab test or corrected serum calcium below 8.5 mEq/L
- Hospitalization within the past 12 months
- Adults unable to consent
- Children
- Pregnant women
- Prisoners
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Low bicarbonate dialysate First
Dialysis with low bicarbonate dialysate (expected normal for an adult ~24 mEq) for the first half of dialysis then switched over to normal bicarbonate dialysate for the second half.
|
|
Active Comparator: Normal bicarbonate dialysate First
Dialysis with normal (37 mEq) for the first half of dialysis then switched over to low bicarbonate dialysate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in the amount of Indoxyl Sulfate level in the first half of dialysis as compared to controls
Time Frame: 1 Minute, 75 Minutes, 105 Minutes, 180 Minutes, 210 Minutes
|
1 Minute, 75 Minutes, 105 Minutes, 180 Minutes, 210 Minutes
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in pH
Time Frame: 1 Minute, 75 Minutes, 105 Minutes, 180 Minutes, 210 Minutes
|
1 Minute, 75 Minutes, 105 Minutes, 180 Minutes, 210 Minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jerome Lowenstein, New York University Medical School
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Actual)
July 1, 2017
Study Completion (Actual)
July 1, 2017
Study Registration Dates
First Submitted
December 22, 2015
First Submitted That Met QC Criteria
December 22, 2015
First Posted (Estimate)
December 24, 2015
Study Record Updates
Last Update Posted (Actual)
July 31, 2017
Last Update Submitted That Met QC Criteria
July 27, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-01343
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemodialysis
-
National Taiwan University HospitalCompletedHemodialysis Complication | Hemodialysis-Induced SymptomTaiwan
-
Osaka UniversityCompleted
-
Chinese PLA General HospitalWithdrawn
-
University of HyogoCompleted
-
DVX, LLCNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Renal...Completed
-
Baxter Healthcare CorporationGambro Renal Products, Inc.Completed
-
Dong-A UniversityCompletedHemodialysisKorea, Republic of
-
Hospital Clinic of BarcelonaFresenius Medical Care Deutschland GmbHCompleted
-
Danish State HospitalUnknown
-
Hamamatsu UniversityCompleted
Clinical Trials on Low bicarbonate dialysate First
-
University of AarhusCompletedEnd Stage Renal Disease on DialysisDenmark
-
Brigham and Women's HospitalRecruitingIntradialytic Hypotension | Peri-dialytic Cardiac Rhythms | Electrolyte Changes | pH Changes | Adverse SymptomsUnited States
-
University of ArkansasHoward J Barnhard, Resident Research Endowment.; UAMS DEPT of Radiology.Completed
-
Prim. Priv. Doz. Dr. Daniel CejkaNot yet recruiting
-
Albert Einstein College of MedicineCompletedChronic Kidney Disease | Metabolic AcidosisUnited States
-
Camillians Saint Mary's Hospital LuodongUnknownEnd Stage Renal Disease on DialysisTaiwan
-
Prim. Priv. Doz. Dr. Daniel CejkaMedice Arzneimittel Pütter GmbH & Co KGWithdrawnKidney Transplant; ComplicationsAustria
-
Alexandria UniversityNot yet recruitingDialysis; ComplicationsEgypt
-
Ege UniversityFresenius Medical Care North AmericaCompletedHemodialysis | End-stage Renal DiseaseTurkey
-
Palo Alto Veterans Institute for ResearchUnknownEnd Stage Renal Failure on DialysisUnited States